Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?

被引：0
|
作者：
Van Eekelen, R. [1 ]
Eijkemans, M. J. [2 ]
Mochtar, M. [1 ]
Mol, F. [1 ]
Mol, B. W. [3 ]
Groen, H. [4 ]
Van Wely, M. [1 ]
机构：
[1] Amsterdam UMC, Acad Med Ctr, Ctr Reprod Med, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr, Dept Biostat & Res Support, Utrecht, Netherlands
[3] Monash Med Ctr, Dept Obstet & Gynaecol, Melbourne, Vic, Australia
[4] Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
来源：
HUMAN REPRODUCTION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-734
引用
收藏
页码：1471 / 1471
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK
    Daya, S
    Ledger, W
    Auray, JP
    Duru, G
    Silverberg, K
    Wikland, M
    Bouzayen, R
    Howles, CM
    Beresniak, A
    HUMAN REPRODUCTION, 2001, 16 (12) : 2563 - 2569
  • [32] Evaluation of the cost-effectiveness of ovulation suppression with progestins compared with GnRH analogs in assisted reproduction cycles
    Evans, M. Blake
    Parikh, Toral
    DeCherney, Alan H.
    Csokmay, John M.
    Healy, Mae W.
    Hill, Micah J.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2019, 38 (05) : 691 - 698
  • [33] The 'Pleasure&Pregnancy' web-based interactive educational programme versus expectant management in the treatment of unexplained subfertility: protocol for a randomised controlled trial
    Dancet, Eline A. F.
    D'Hooghe, Thomas M.
    Dreischor, Felicia
    van Wely, Madelon
    Laan, Ellen T. M.
    Lambalk, Cornelius B.
    Repping, Sjoerd
    Custers, Inge M.
    BMJ OPEN, 2019, 9 (07):
  • [34] Cost-effectiveness analysis in the health sector when there is a private alternative to public treatment
    Hoel, Michael
    CESIFO ECONOMIC STUDIES, 2006, 52 (03) : 500 - 512
  • [35] Decision analysis on effectiveness and cost-effectiveness of disease management programs for the treatment of heart failure
    Goehler, A
    Dietz, R
    Osterziel, KJ
    Siebert, U
    VALUE IN HEALTH, 2004, 7 (06) : 699 - 699
  • [36] COST-EFFECTIVENESS ANALYSIS OF HCG AND HUMAN GONADOTROPINS IN MEN WITH HYPOGONADOTROPIC HYPOGONADISM IN THE CONTEXT OF AN ASSISTED REPRODUCTION PROGRAM
    Chamberland, C.
    VALUE IN HEALTH, 2014, 17 (03) : A250 - A250
  • [37] COST-EFFECTIVENESS ANALYSIS OF RESMETIROM: AN INVESTIGATIONAL TREATMENT FOR THE MANAGEMENT OF NONALCOHOLIC STEATOHEPATITIS
    Javanbakht, M.
    Fishman, J.
    Moloney, E.
    Rydqvist, P.
    Ansaripour, A.
    VALUE IN HEALTH, 2022, 25 (07) : S395 - S395
  • [38] THE COST-EFFECTIVENESS OF ENDOSCOPIC TREATMENT AND OPEN SURGERY IN THE MANAGEMENT OF VESICOURETERAL REFLUX
    Tarcan, Tufan
    Akbal, Cem
    Tavukcu, Hasan Huseyin
    Simsek, Ferruh
    TURKISH JOURNAL OF UROLOGY, 2007, 33 (01): : 86 - 91
  • [39] The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
    Marseille, Elliot
    Kahn, James G.
    Yazar-Klosinski, Berra
    Doblin, Rick
    PLOS ONE, 2020, 15 (10):
  • [40] Selective fetoscopic laser or expectant management for quintero stage i twin-twin transfusion: a cost-effectiveness analysis
    Stone, Jordan
    Shaaban, Aimen
    Grobman, William A.
    Premkumar, Ashish
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S212 - S213
12345